@article{ca7ad8d50a51401dbc1c5fcac7dc547d,
title = "Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)",
keywords = "Antiarrhythmic drugs, Arrhythmias, Atrial fibrillation, Bradycardia, EHRA consensus document, Extrasystoles, Pre-excitation, Proarrhythmias, Sudden cardiac death, Supraventricular arrhythmias, Ventricular tachycardia",
author = "Gheorghe-Andrei Dan and Antoni Martinez-Rubio and Stefan Agewall and Giuseppe Boriani and Martin Borggrefe and Fiorenzo Gaita and {van Gelder}, Isabelle and Bulent Gorenek and Kaski, {Juan Carlos} and Keld Kjeldsen and Lip, {Gregory Y H} and Bela Merkely and Ken Okumura and Piccini, {Jonathan P} and Tatjana Potpara and Poulsen, {Birgitte Klindt} and Magdi Saba and Irina Savelieva and Tamargo, {Juan L} and Christian Wolpert and {ESC Scientific Document Group}",
note = "A correction has been published: EP Europace, Volume 20, Issue 5, 1 May 2018, Pages 738, https://doi.org/10.1093/europace/euy119",
year = "2018",
month = may,
day = "1",
doi = "10.1093/europace/eux373",
language = "English",
volume = "20",
pages = "731--732an",
journal = "Europace",
issn = "1099-5129",
publisher = "Oxford University Press",
number = "5",
}